A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.
Part of paid clinical trials in Sacramento, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT02960854
- Phase
- PHASE1
- Status
- Completed
Conditions
- Severe Sepsis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nivolumab — BIOLOGICALSpecified dose on specified days
Study Details
A study to evaluate the safety, tolerability and pharmacokinetics of Nivolumab in participants with severe sepsis or septic shock.
Key Dates
- Start date
- Dec 7, 2016
- Status verified
- Apr 2019
- Primary completion
- Jan 5, 2018
- Completion
- Jan 5, 2018
Study Design
- Enrollment
- 38 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Nivolumab 1Dose 1
- Experimental: Nivolumab 2Dose 2
Primary Outcome Measure
Percentage of Incidence Rates of Serious Adverse Events (SAEs), Adverse Events (AEs), Immune-mediated AEs, AEs Leading to Discontinuation, and Deaths [ Time Frame: Screening, day -1, day 1 and subsequent days after, up to 90 days ]
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Uc Davis Medical Center | Sacramento | California | 95817 | - |
| Univ. Of Colorado Health | Colorado Springs | Colorado | 80909 | - |
| Denver Health Medical Center | Denver | Colorado | 80204 | - |
| University Of Florida | Gainesville | Florida | 32610 | - |
| Pulmonary And Critical Care Of Atlanta | Atlanta | Georgia | 30303 | - |
| Osf Saint Francis Medical Center | Peoria | Illinois | 61637 | - |
| University Of Kentucky | Lexington | Kentucky | 40536 | - |
| Beth Israel Deaconess Medical Center (BIDMC) | Boston | Massachusetts | 02215 | - |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | - |
| University of Michigan, Division of Acute Care Surgery | Ann Arbor | Michigan | 48109-5008 | - |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | - |
| Duke University Medical Center | Durham | North Carolina | 27710 | - |
| The Ohio State University | Columbus | Ohio | 43210 | - |
| UPMC | Pittsburgh | Pennsylvania | 15261-2500 | - |
| Harborview Medical Center | Seattle | Washington | 98104 | - |
Find similar trials in Sacramento, CA
Related Studies
- Sepsis Clinical Decision Support [CDS] Master Enrollment Study ProtocolEnrolling By Invitation · Beckman Coulter, Inc. · Irvine, California
- Alveolar Dead Space as Predictor of Organ Failure in Severe SepsisNot Yet Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas